Champeroux P - Search Results

1

Relevance of electroencephalogram assessment in amyloid and tau pathology in rat.

Maleysson V, Page G, Janet T, Klein RL, Haida O, Maurin A, Richard S, Champeroux P, Fauconneau B. Maleysson V, et al. Among authors: champeroux p. Behav Brain Res. 2019 Feb 1;359:127-134. doi: 10.1016/j.bbr.2018.10.026. Epub 2018 Oct 24. Behav Brain Res. 2019. PMID: 30367970

2

Calculation of QT shift in non clinical safety pharmacology studies.

Champeroux P, Martel E, Fowler JS, Maurin A, Sola ML, Jude S, Elamrani F, Weyn AA, Laveissiere A, Lala P, Richard S. Champeroux P, et al. J Pharmacol Toxicol Methods. 2009 Mar-Apr;59(2):73-85. doi: 10.1016/j.vascn.2008.11.001. Epub 2008 Dec 10. J Pharmacol Toxicol Methods. 2009. PMID: 19135537

3

Interferences of the autonomic nervous system with drug induced QT prolongation: a point to consider in non-clinical safety studies.

Champeroux P, Ouillé A, Martel E, Fowler JS, Maurin A, Jude S, Lala P, Le Guennec JY, Richard S. Champeroux P, et al. J Pharmacol Toxicol Methods. 2010 May-Jun;61(3):251-63. doi: 10.1016/j.vascn.2010.02.006. Epub 2010 Feb 19. J Pharmacol Toxicol Methods. 2010. PMID: 20172034

4

A step towards characterisation of electrophysiological profile of torsadogenic drugs.

Champeroux P, Ouillé A, Martel E, Fowler JS, Maurin A, Richard S, Le Guennec JY. Champeroux P, et al. J Pharmacol Toxicol Methods. 2011 May-Jun;63(3):269-78. doi: 10.1016/j.vascn.2011.01.001. Epub 2011 Jan 9. J Pharmacol Toxicol Methods. 2011. PMID: 21224008

5

Power spectral analysis of heart rate variability in cynomolgus monkeys in safety pharmacology studies: comparative study with beagle dogs.

Champeroux P, Martel E, Jude S, Laigot C, Laveissière A, Weyn-Marotte AA, Fowler JS, Maurin A, Richard S, Babuty D. Champeroux P, et al. J Pharmacol Toxicol Methods. 2013 Jul-Aug;68(1):166-74. doi: 10.1016/j.vascn.2013.02.005. Epub 2013 Feb 19. J Pharmacol Toxicol Methods. 2013. PMID: 23435316

6

Short-term variability in QT interval and ventricular arrhythmias induced by dofetilide are dependent on high-frequency autonomic oscillations.

Champeroux P, Thireau J, Judé S, Laigot-Barbé C, Maurin A, Sola ML, Fowler JS, Richard S, Le Guennec JY. Champeroux P, et al. Br J Pharmacol. 2015 Jun;172(11):2878-91. doi: 10.1111/bph.13093. Epub 2015 Mar 26. Br J Pharmacol. 2015. PMID: 25625756 Free PMC article.

7

The high frequency relationship: implications for torsadogenic hERG blockers.

Champeroux P, Le Guennec JY, Jude S, Laigot C, Maurin A, Sola ML, Fowler JS, Richard S, Thireau J. Champeroux P, et al. Br J Pharmacol. 2016 Feb;173(3):601-12. doi: 10.1111/bph.13391. Epub 2016 Jan 14. Br J Pharmacol. 2016. PMID: 26589499 Free PMC article.

8

[No title available]

[No authors listed] [No authors listed] PMID: 31963046

9

High-frequency autonomic modulation: a new model for analysis of autonomic cardiac control.

Champéroux P, Fesler P, Judé S, Richard S, Le Guennec JY, Thireau J. Champéroux P, et al. Br J Pharmacol. 2018 Aug;175(15):3131-3143. doi: 10.1111/bph.14354. Epub 2018 Jun 15. Br J Pharmacol. 2018. PMID: 29723392 Free PMC article.

10

An optimised methodology for the neurobehavioural assessment in rodents.

Moscardo E, Maurin A, Dorigatti R, Champeroux P, Richard S. Moscardo E, et al. Among authors: champeroux p. J Pharmacol Toxicol Methods. 2007 Sep-Oct;56(2):239-55. doi: 10.1016/j.vascn.2007.03.007. Epub 2007 May 24. J Pharmacol Toxicol Methods. 2007. PMID: 17629504

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

51 results

Search Page